Given the involvement of cholesterol/EGFR/Src/Erk/SP1/ERRα axis in the EGFR-TKIs resistance, we tested whether lowing cholesterol in lipid rafts and inhibiting ERRα expression could affect the sensitivity of EGFR-TKIs in NSCLC. The gene discussed is SP1; the disease is non-small cell lung carcinoma.